Best of 2020: Top pharma stories
MM+M’s most popular pharma stories of the year spanned features the industry’s reaction to the death of George Floyd and COVID-19, surveys on how to navigate challenges due to the pandemic and more.
News
Five things for pharma marketers to know: Monday, December 28, 2020
Justice Department takes aim at Walmart over opioid prescriptions; vaccine skepticism raises concerns; BMS suspends Opdivo trials in brain cancer.
Best of 2020: Top media stories
The most-read media stories on MM+M included media acquisitions, Q&As with health media and point-of-care leaders and coverage of virtual health media events.
Five things for pharma marketers to know: Wednesday, December 23, 2020
Texas deviates from CDC vaccination priority guidelines; Answering questions about the new strain of COVID-19; EU approves Pfizer/BioNTech vaccine.
Best of 2020: Top MM+M campaign stories
Browse a list of MM+M’s most popular campaign stories from 2020 featuring videos, campaign mishaps, celebrities and more.
Only thing more shameful than Purdue’s misleading opioid marketing: Sacklers’ refusal to accept blame
Family members ducked responsibility for Purdue’s marketing misdeeds, despite exerting substantial oversight over the company’s management for many years.
Coronavirus Briefing: 2020 mercifully nears an end, COVID relief finally passes the Senate, more shots go into more arms
This week’s Haymarket Media Coronavirus Briefing is 1,358 words and will take you six minutes to read.
A Q&A with Razorfish Health’s Kara Dugan
The company’s new president talks virtual agency life, leadership succession and plans/priorities.
Best of 2020: Top agency stories
Take a look back at the most-read agency stories of 2020 including agency reactions to the pandemic and George Floyd’s death, 2020 Agency 100 results and more.
Want to read more?
Please login or register first to view this content.
